Following Investor Connect's news feed is very easy. Subscribe using the "follow" button on the top right and if you want to, choose the updates by topic or tag.
We will deliver them to your inbox, your phone, or you can use follow.it like your own online RSS reader. You can unsubscribe whenever you want with one click.
Keep up to date with Investor Connect!
Investor Connect: Investor Connect: We help Startups and Investors connect for funding
Is this your feed? Claim it!
How To Handle an Exploding Term Sheet Hello, this is Hall T. Martin with the Startup Funding Espresso — your daily shot of startup funding and investing. An exploding term sheet is one that comes with a specific deadline, including a time of day and date. It often gives the founder very little time to […]
The post
Key Factors Impacting Investor Returns Hello, this is Hall T. Martin with the Startup Funding Espresso — your daily shot of startup funding and investing. Startup investors seeking higher returns should consider the following factors: Due diligence — there must be a meaningful amount of due diligence performed on the startup before investing to increase […]
The post
Building a Startup Portfolio Hello, this is Hall T. Martin with the Startup Funding Espresso — your daily shot of startup funding and investing. Startup investing requires a portfolio approach. Here are some best practices for building a startup portfolio. Determine how much time and investment dollars to allocate to startup funding. This could be […]
The post
What To Include in a Due Diligence Report Hello, this is Hall T. Martin with the Startup Funding Espresso — your daily shot of startup funding and investing. The due diligence report is written by the due diligence team. It covers the financial, operational, legal, and strategic aspects of the startup. A due diligence report […]
The post
On this episode of Investor Connect, Hall Marchant welcomes Gillian Fenton of LST Strategies, who brings more than 30 years of experience in licensing intellectual property and life sciences transactions, including work with GSK, Emergent BioSolutions, and Biogen, as well as university startups, established life science companies, and investors. Gillian...
The post